9 September 2021

EULAR Reactive Arthritis

Progress in targeted therapy for lupus

2 September 2021

COVID-19 EULAR

Covid and RMD patients in Europe

2 September 2021

COVID-19 EULAR

Drug holiday boosts rheuma patient covid vax success: latest ACR update

26 August 2021

EULAR

APLAR 2021 preview

6 May 2021

EULAR Mental Health Reactive Arthritis Scleroderma Spondyloarthritis

Treat depression and anxiety for better PsA outcomes

16 April 2019

Ankylosing Spondylitis Biologics EULAR

Game-changing RA drugs out of Third World’s reach

16 April 2019

EULAR Evidence Based

Move over, RCT

12 April 2019

Analgesics Conditions EULAR Spondyloarthritis

APLAR interviews: RA treatment in 2030

10 April 2019

DMARDS EULAR

APLAR interviews: Telerheumatology

10 April 2019

Conditions EULAR

APLAR interviews: Takayasu arteritis

10 April 2019

EULAR

Too soon for T2T in SpA

10 April 2019

EULAR Spondyloarthritis

The hunt for the perfect predictor

29 March 2019

EULAR

HK society celebrates 30 years of growth

29 March 2019

EULAR

Not just a congress, a collaboration platform

18 March 2019

EULAR

From the president: APLAR at a glance

18 March 2019

EULAR

Meet the Asia Pacific’s young rheumatologists